Skip to content

The application of bedside ultrasound in the treatment of patients with ovarian cancer cell reduction surgery

The application of bedside ultrasound in the treatment of patients with ovarian cancer cell reduction surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039113
Enrollment
Unknown
Registered
2020-10-17
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pulmonary complications

Interventions

Gold Standard:Clinical outcomes
Index test:1.&#32
&#32
mobility. 2.&#32
The&#32
of&#32
muscle
the&#32

Sponsors

The First Affiliated Hospital of USTC Anhui Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old, ASA I - III, no gender restriction, BMI = < 35kg / m2; 2. Patients who plan to undergo cytoreductive surgery for ovarian cancer.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of neuromuscular diseases; 2. Patients with history of thoracic surgery; 3. Patients with phrenic nerve paralysis; 4. Patients who have been diagnosed with pulmonary complications before operation.

Design outcomes

Primary

MeasureTime frame
Diaphragm Thickness;Diaphragmatic inspiratory amplitude;Change in Thickness of diaphram;Intercostal Muscle Thickness;Change in Thickness of Intercostal Muscle;atelectasis;lung consolidation;pleural effusion;

Countries

China

Contacts

Public ContactZhang Wei

Anhui Provincial Hospital of the First Affiliated Hospital of China University of Science and Technology

zw97079@163.com+86 13856042616

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026